Publications (original articles or review articles) published in 2023 from OUS - Department of Haematology
80 publications found
Cognitive development among children in a low-income setting: Cost-effectiveness analysis of a maternal nutrition education intervention in rural Uganda
PLoS One, 18 (8), e0290379
DOI 10.1371/journal.pone.0290379, PubMed 37594989
Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study
Cancer, 129 (17), 2645-2654
DOI 10.1002/cncr.34843, PubMed 37269074
Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial
Transplant Cell Ther, 29 (6), 364.e1-364.e11
DOI 10.1016/j.jtct.2023.02.023, PubMed 36878428
Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling
Cell Rep Methods, 3 (12), 100654
DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095
Refractory immune thrombocytopenia in adults: Towards a new definition
Br J Haematol, 203 (1), 23-27
DOI 10.1111/bjh.19075, PubMed 37642211
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
Haemophilia, 29 (4), 1032-1038
DOI 10.1111/hae.14806, PubMed 37252898
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
Ther Adv Hematol, 14, 20406207231202306
DOI 10.1177/20406207231202306, PubMed 37859645
Standardized assays to monitor drug sensitivity in hematologic cancers
Cell Death Discov, 9 (1), 435
DOI 10.1038/s41420-023-01722-5, PubMed 38040674
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party
Clin Cancer Res, 29 (21), 4441-4448
DOI 10.1158/1078-0432.CCR-23-0954, PubMed 37603683
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial
Am J Hematol, 99 (1), 57-67
DOI 10.1002/ajh.27131, PubMed 38014779
Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
BMC Infect Dis, 23 (1), 247
DOI 10.1186/s12879-023-08182-3, PubMed 37072711
Predictors for achieving adequate antenatal care visits during pregnancy: a cross-sectional study in rural Northwest Rwanda
BMC Pregnancy Childbirth, 23 (1), 69
DOI 10.1186/s12884-023-05384-0, PubMed 36703102
Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
Ther Adv Hematol, 14, 20406207231184323
DOI 10.1177/20406207231184323, PubMed 37529276
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
Scand J Immunol, 98 (1), e13274
DOI 10.1111/sji.13274, PubMed 37676118
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
Front Immunol, 14, 1210899
DOI 10.3389/fimmu.2023.1210899, PubMed 37503339
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy
Leukemia, 37 (9), 1842-1849
DOI 10.1038/s41375-023-01980-3, PubMed 37507426
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
Ann Hematol, 102 (6), 1395-1408
DOI 10.1007/s00277-023-05199-1, PubMed 37119314
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
Nat Cancer, 4 (10), 1474-1490
DOI 10.1038/s43018-023-00642-8, PubMed 37783807
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party
Bone Marrow Transplant, 59 (2), 255-263
DOI 10.1038/s41409-023-02154-6, PubMed 38062242
Does the clot burden as assessed by the Mean Bilateral Proximal Extension of the Clot score reflect mortality and adverse outcome after pulmonary embolism?
Acta Radiol Open, 12 (6), 20584601231187094
DOI 10.1177/20584601231187094, PubMed 37426515
Avapritinib versus Placebo in Indolent Systemic Mastocytosis
NEJM Evid, 2 (6), EVIDoa2200339
DOI 10.1056/EVIDoa2200339, PubMed 38320129
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
Hemasphere, 7 (9), e940
DOI 10.1097/HS9.0000000000000940, PubMed 37663673
The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
Ann Hematol, 102 (4), 927-935
DOI 10.1007/s00277-023-05149-x, PubMed 36864210
Scalable production of tissue-like vascularized liver organoids from human PSCs
Exp Mol Med, 55 (9), 2005-2024
DOI 10.1038/s12276-023-01074-1, PubMed 37653039
Effects of Agricultural Intensification on Mediterranean Diets: A Narrative Review
Foods, 12 (20)
DOI 10.3390/foods12203779, PubMed 37893672
A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
Cell Death Discov, 9 (1), 125
DOI 10.1038/s41420-023-01426-w, PubMed 37055391
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Bone Marrow Transplant, 58 (12), 1357-1367
DOI 10.1038/s41409-023-02094-1, PubMed 37679647
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
J Thromb Haemost, 21 (10), 2771-2775
DOI 10.1016/j.jtha.2023.07.019, PubMed 37543216
Fluid and water balance: a scoping review for the Nordic Nutrition Recommendations 2023
Food Nutr Res, 67
DOI 10.29219/fnr.v67.9975, PubMed 38084150
Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
Thromb Res, 229, 7-14
DOI 10.1016/j.thromres.2023.06.004, PubMed 37356172
The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
Chest, 164 (4), 981-991
DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
J Thromb Haemost, 22 (2), 526-533
DOI 10.1016/j.jtha.2023.10.017, PubMed 37913911
Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
J Thromb Haemost, 21 (10), 2824-2832
DOI 10.1016/j.jtha.2023.06.028, PubMed 37394122
Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
Laryngoscope Investig Otolaryngol, 9 (1), e1196
DOI 10.1002/lio2.1196, PubMed 38362186
No difference in quality of life between persons with severe haemophilia A and B
Haemophilia, 29 (4), 987-996
DOI 10.1111/hae.14759, PubMed 36791275
Low vitamin B12 blood levels in sickle cell disease: Data from a large cohort study in Tanzania
Br J Haematol, 204 (3), 1047-1053
DOI 10.1111/bjh.19265, PubMed 38087805
Health-related quality of life in adults with drug-resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial
Epilepsia, 64 (5), e69-e74
DOI 10.1111/epi.17585, PubMed 36923995
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
Cell Rep Methods, 3 (3), 100417
DOI 10.1016/j.crmeth.2023.100417, PubMed 37056380
Arterial events in cancer patients treated with apixaban for venous thrombosis
Thromb Res, 228, 128-133
DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Lancet Oncol, 24 (6), e255-e269
DOI 10.1016/S1470-2045(23)00159-6, PubMed 37269857
Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers
Haemophilia, 29 (2), 658-667
DOI 10.1111/hae.14752, PubMed 36723510
Factors associated with physical activity in young people with haemophilia A on prophylaxis
Haemophilia, 29 (3), 900-909
DOI 10.1111/hae.14776, PubMed 36913380
Barriers and facilitators to implementation of nutrition-related actions in school settings in low- and middle-income countries (LMICs): a qualitative systematic review using the Consolidated Framework for Implementation Research (CFIR)
Implement Sci Commun, 4 (1), 73
DOI 10.1186/s43058-023-00454-y, PubMed 37370179
Stress biomarkers in adult patients with drug-resistant epilepsy on a modified Atkins diet: A prospective study
Epilepsia Open, 8 (4), 1331-1339
DOI 10.1002/epi4.12808, PubMed 37574592
Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden
Haematologica, 108 (6), 1640-1651
DOI 10.3324/haematol.2021.280424, PubMed 36300775
The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients-a single-arm prospective trial
Pilot Feasibility Stud, 9 (1), 195
DOI 10.1186/s40814-023-01415-x, PubMed 38042811
Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
Haemophilia, 30 (1), 98-105
DOI 10.1111/hae.14899, PubMed 37983883
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
Bone Marrow Transplant, 58 (12), 1339-1347
DOI 10.1038/s41409-023-02095-0, PubMed 37660157
Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
Bone Marrow Transplant, 58 (7), 791-800
DOI 10.1038/s41409-023-01980-y, PubMed 37045942
Food insecurity, dietary diversity and the right to adequate food among households in landslide-prone communities in Eastern Uganda: A cohort study
PLoS One, 18 (4), e0283078
DOI 10.1371/journal.pone.0283078, PubMed 37053147
Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
Bone Marrow Transplant, 58 (10), 1069-1074
DOI 10.1038/s41409-023-02072-7, PubMed 37528237
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation
Leukemia, 37 (10), 2107-2114
DOI 10.1038/s41375-023-01998-7, PubMed 37568010
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
Clin Lymphoma Myeloma Leuk, 24 (3), 165-176.e4
DOI 10.1016/j.clml.2023.10.009, PubMed 38072743
Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of HNRNPH1 With MLLT10
Cancer Genomics Proteomics, 20 (4), 354-362
DOI 10.21873/cgp.20387, PubMed 37400142
Decreased serum concentrations of antiseizure medications in children with drug resistant epilepsy following treatment with ketogenic diet
Epilepsia Open, 8 (3), 858-866
DOI 10.1002/epi4.12746, PubMed 37057954
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma
Clin Hematol Int, 5 (1), 43-51
DOI 10.1007/s44228-022-00023-5, PubMed 36656461
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype
Bone Marrow Transplant, 59 (2), 264-269
DOI 10.1038/s41409-023-02167-1, PubMed 38092959
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study
Thromb Haemost, 123 (7), 692-699
DOI 10.1055/a-2039-3388, PubMed 36809776
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study
Ther Adv Hematol, 14, 20406207231166779
DOI 10.1177/20406207231166779, PubMed 37113811
Breeding Bread-Making Wheat Varieties for Organic Farming Systems: The Need to Target Productivity, Robustness, Resource Use Efficiency and Grain Quality Traits
Foods, 12 (6)
DOI 10.3390/foods12061209, PubMed 36981136
Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Transplant Cell Ther, 30 (2), 235.e1-235.e10
DOI 10.1016/j.jtct.2023.11.017, PubMed 38007092
"iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives"
Front Physiol, 14, 1094249
DOI 10.3389/fphys.2023.1094249, PubMed 36711019
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
Leukemia, 37 (6), 1349-1360
DOI 10.1038/s41375-023-01883-3, PubMed 37024520
Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
EJHaem, 4 (4), 1117-1131
DOI 10.1002/jha2.743, PubMed 38024633
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplant, 58 (11), 1197-1202
DOI 10.1038/s41409-023-02075-4, PubMed 37553468
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study
Eur J Haematol, 112 (3), 402-411
DOI 10.1111/ejh.14127, PubMed 37968873
Plasminogen, human-tvmh for the treatment of children and adults with plasminogen deficiency type 1
Haemophilia, 29 (6), 1556-1564
DOI 10.1111/hae.14849, PubMed 37674358
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
N Engl J Med, 390 (4), 301-313
DOI 10.1056/NEJMoa2312054, PubMed 38084760
Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
Clin Lymphoma Myeloma Leuk, 23 (9), 687-696
DOI 10.1016/j.clml.2023.05.004, PubMed 37355418
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Bone Marrow Transplant, 59 (2), 217-223
DOI 10.1038/s41409-023-02139-5, PubMed 37978322
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Leukemia, 37 (6), 1175-1185
DOI 10.1038/s41375-023-01920-1, PubMed 37142661
Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19
J Intern Med, 294 (6), 721-729
DOI 10.1111/joim.13706, PubMed 37518983
Early response evaluation by single cell signaling profiling in acute myeloid leukemia
Nat Commun, 14 (1), 115
DOI 10.1038/s41467-022-35624-4, PubMed 36611026
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
DOI 10.1186/s13054-022-04205-8, PubMed 36627655
Adult presentation of ornithine transcarbamylase deficiency: a possible cause of hyperammonemia after high-dose chemotherapy and stem cell transplantation
Hematology, 28 (1), 2265187
DOI 10.1080/16078454.2023.2265187, PubMed 38078487
Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial
Res Pract Thromb Haemost, 8 (1), 102289
DOI 10.1016/j.rpth.2023.102289, PubMed 38292350
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
Lancet Oncol, 24 (10), 1119-1133
DOI 10.1016/S1470-2045(23)00405-9, PubMed 37717583
Allogeneic stem cell transplantation in adults 2015-21
Tidsskr Nor Laegeforen, 143 (4)
DOI 10.4045/tidsskr.22.0521, PubMed 36919291
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
Res Pract Thromb Haemost, 7 (4), 100164
DOI 10.1016/j.rpth.2023.100164, PubMed 37255854
Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma: H chain-loss escapees cause FLC MM
J Immunother Cancer, 11 (8)
DOI 10.1136/jitc-2023-006944, PubMed 37607769